Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis

被引:30
作者
Espejo, C
Penkowa, M
Demestre, M
Montalban, X
Martinez-Caceres, EM
机构
[1] Univ Barcelona, Hosp Vall Hebron, Unitat Neuroimmunol Clin, Barcelona 08035, Spain
[2] Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark
[3] Inst Invest Ciencies Salut Germans Trias & Pujol, Transfus & Tissue Bank, CTBT, Lab Immunol Appl Diagnosis LIRAD, Badalona, Barcelona, Spain
关键词
multiple sclerosis; oxidative stress; antioxidant; neuroprotection;
D O I
10.1016/j.neuroscience.2005.01.057
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Experimental autoimmune encephalomyelitis (EAE) is an animal model for multiple sclerosis (MS). EAE and MS are characterized by CNS inflammation, demyelination and neurodegeneration. The inflammatory response occurring within the CNS leads to glial activation, dysfunction and death, as well as axonal damage and neurological deficit. Although the pathogenic mechanisms involved in EAE/MS are not well understood, accumulating data suggest that oxidative stress plays a major role in lesion development, and contributes to axonal dysfunction and degeneration. Metallothionein-I and -II are anti-inflammatory, neuroprotective, antioxidant proteins expressed during EAE and MS, in which they might play a protective role. The present study aimed to describe the expression profile of a group of inflammatory, neurodegenerative and tissue repair markers as well as metallothioneins during proteolipid protein-induced EAE, and to establish the time-relationships these molecules had during EAE. Interestingly, we found two marker expression profiles. In the first, marker expression increased as clinical signs worsened and reverted to baseline expression during recovery; in the second, marker expression increased at a later point during relapse, peaked at highest clinical score, and remained elevated throughout recovery. Of note, metallothionein expression was found to be related to the second profile, which would suggest that metallothionein proteins are implicated in the clinical recovery of EAE and perhaps these antioxidant proteins may provide therapeutic benefits in MS. (c) 2005 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1135 / 1149
页数:15
相关论文
共 67 条
  • [1] Regulation of metallothionein gene expression by oxidative stress and metal ions
    Andrews, GK
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (01) : 95 - 104
  • [2] Aschner M, 1998, NEUROTOXICOLOGY, V19, P653
  • [3] The functional significance of brain metallothioneins
    Aschner, M
    [J]. FASEB JOURNAL, 1996, 10 (10) : 1129 - 1136
  • [4] Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
    Bagasra, O
    Michaels, FH
    Zheng, YM
    Bobroski, LE
    Spitsin, SV
    Fu, ZF
    Tawadros, R
    Koprowski, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) : 12041 - 12045
  • [5] Bettelli E, 1998, J IMMUNOL, V161, P3299
  • [6] Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
    Bjartmar, C
    Wujek, JR
    Trapp, BD
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) : 165 - 171
  • [7] Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870
  • [8] Interleukin-6 and tumor necrosis factor-α type 1 receptor deficient mice reveal a role of IL-6 and TNF-α on brain metallothionein-I and -III regulation
    Carrasco, J
    Hernandez, J
    Bluethmann, H
    Hidalgo, J
    [J]. MOLECULAR BRAIN RESEARCH, 1998, 57 (02): : 221 - 234
  • [9] An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
    Cassarino, DS
    Bennett, JP
    [J]. BRAIN RESEARCH REVIEWS, 1999, 29 (01) : 1 - 25
  • [10] Cohen RI, 1996, J NEUROSCI, V16, P6433